← Back to Search

Robotic Surgery

Robotic Assisted Surgery for Colorectal Cancer

N/A
Waitlist Available
Led By David Larson, MD, MBA
Research Sponsored by Intuitive Surgical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Willing and able to comply with the study protocol requirements including perioperative follow-up examinations at 14 days, 42 days post operatively, and post-market long-term follow-up on an annual basis through 5 years
Age ≥ 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up intraoperative through the 42-day postoperative period
Awards & highlights

Study Summary

This trial is testing the safety and performance of the da Vinci SP surgical system in complex colorectal procedures.

Who is the study for?
Adults with colorectal cancer who need complex surgery and have a BMI ≤ 35, ASA score ≤ 3 (indicating they're fit for surgery), and no widespread cancer. They must be able to follow the study plan, including visits up to 5 years after surgery.Check my eligibility
What is being tested?
The trial is testing the safety and performance of the da Vinci SP Surgical System in single-port robotic-assisted surgeries like low anterior resections or right colectomies for colorectal cancer.See study design
What are the potential side effects?
Potential side effects may include typical surgical risks such as pain, infection at the incision site, bleeding, blood clots, and reactions to anesthesia. Specific side effects related to robotic-assisted surgery will be monitored.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can follow the study's schedule for check-ups and long-term follow-up for 5 years.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intraoperative period
This trial's timeline: 3 weeks for screening, Varies for treatment, and intraoperative period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Events Rates
Performance

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single armExperimental Treatment1 Intervention
Colorectal procedure will be performed by da Vinci SP® Surgical System

Find a Location

Who is running the clinical trial?

Intuitive SurgicalLead Sponsor
73 Previous Clinical Trials
49,199 Total Patients Enrolled
Kathryn WineStudy DirectorMedical Affairs Director
1 Previous Clinical Trials
204 Total Patients Enrolled
David Larson, MD, MBAPrincipal InvestigatorMayo Clinic

Media Library

da Vinci SP Surgical System (Robotic Surgery) Clinical Trial Eligibility Overview. Trial Name: NCT04403022 — N/A
Colorectal Cancer Research Study Groups: Single arm
Colorectal Cancer Clinical Trial 2023: da Vinci SP Surgical System Highlights & Side Effects. Trial Name: NCT04403022 — N/A
da Vinci SP Surgical System (Robotic Surgery) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04403022 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies still available in this research effort?

"Affirmative. Clinicaltrials.gov data reveals that this clinical trial, which was initially posted on June 3rd 2021, is actively recruiting patients. This investigation requires the recruitment of 60 participants from three distinct sites."

Answered by AI

What is the maximum capacity for participants in this experiment?

"In order to complete this clinical trial, 60 volunteers who meet the pre-determined qualifications must partake in it. Participants may have access to these medical services at Adventist Health System/Sunbelt in Orlando or Mayo Clinic in Rochester."

Answered by AI
~16 spots leftby Apr 2025